Breaking News Instant updates and real-time market news.

OTIC

Otonomy

$19.55

0.5 (2.62%)

07:34
07/18/17
07/18
07:34
07/18/17
07:34

Otonomy announces FDA acceptance of OTIPRIO sNDA

Otonomy announced that its Supplemental New Drug Application, or sNDA, for the approval of OTIPRIO as a treatment of acute otitis externa, or AOE, has been accepted for filing by the FDA and been assigned a Prescription Drug User Fee Act action date of March 2, 2018. The acceptance of the sNDA indicates that the application is sufficiently complete to permit a substantive review by the FDA.

OTIC Otonomy
$19.55

0.5 (2.62%)

03/09/17
RHCO
03/09/17
NO CHANGE
RHCO
Otonomy should be bought on weakness, says SunTrust
After meeting with Otonomy's management, SunTrust analyst Edward Nash thinks that the company's new commercial strategy and organizational structure will remedy the demand issues facing its Otiprio treatment. The analyst recommends buying the stock on weakness.
05/08/17
RHCO
05/08/17
NO CHANGE
RHCO
Otonomy should be bought ahead of Phase III data, says SunTrust
SunTrust analyst Edward Nash expects Phase III data on Otonomy's OTIVIDEX for Meniere's disease, due out in Q2, to be positive. The analyst remains upbeat on the outlook for OTIVIDEX and recommends buying the shares ahead of the data. He keeps a $45 price target and a Buy rating on the shares.
06/02/17
PIPR
06/02/17
INITIATION
Target $32
PIPR
Overweight
Otonomy assumed with an Overweight at Piper Jaffray
Piper Jaffray analyst Charles Duncan assumed coverage of Otonomy with an Overweight rating and $32 price target. The analyst believes the company has a "novel drug delivery platform."
06/23/17
RHCO
06/23/17
NO CHANGE
RHCO
Otonomy trial has high probability of success, says SunTrust
After Otonomy announced the results of its meeting with the FDA and announced the design of a Phase III trial of its Otiprio drug in acute otitis media with tympanostomy tubes, SunTrust analyst Edward Nash says the fact that the control subjects in the study will receive no treatment indicates that the trial has "a very high probability of success". The analyst predicts that Otonomy will generate $158M in revenue from Otiprio in 2025. He keeps a $45 price target and a Buy rating on the shares.

TODAY'S FREE FLY STORIES

VIX

Volatility Index S&P 500 Options

16:20
10/17/17
10/17
16:20
10/17/17
16:20
Options
Closing CBOE SPX and VIX Index summary for October 17th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRCY

Mercury Systems

$51.10

-0.61 (-1.18%)

16:19
10/17/17
10/17
16:19
10/17/17
16:19
Hot Stocks
Mercury Systems awarded $4.7M in orders for airborne radio frequency subsystems »

Mercury Systems received…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 24

    Oct

  • 07

    Nov

$NSD

NASDAQ Market Internals

16:17
10/17/17
10/17
16:17
10/17/17
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

16:16
10/17/17
10/17
16:16
10/17/17
16:16
Technical Analysis
NYSE market internals summary »

Volume was below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$199.48

-3.2 (-1.58%)

, UNH

UnitedHealth

$203.92

10.72 (5.55%)

16:15
10/17/17
10/17
16:15
10/17/17
16:15
General news
On The Fly: Top stock stories for Tuesday »

Stocks opened little…

NFLX

Netflix

$199.48

-3.2 (-1.58%)

UNH

UnitedHealth

$203.92

10.72 (5.55%)

JNJ

Johnson & Johnson

$140.75

4.63 (3.40%)

GS

Goldman Sachs

$236.08

-6.335 (-2.61%)

MS

Morgan Stanley

$49.13

0.19 (0.39%)

AET

Aetna

$155.91

4.47 (2.95%)

ANTM

Anthem

$187.29

3.53 (1.92%)

CNC

Centene

$93.78

2.86 (3.15%)

CI

Cigna

$187.20

2.21 (1.19%)

HUM

Humana

$240.54

3.37 (1.42%)

MOH

Molina Healthcare

$61.54

1.675 (2.80%)

WCG

WellCare

$174.06

6.14 (3.66%)

CYH

Community Health

$6.44

0.54 (9.15%)

HCA

HCA Healthcare

$76.81

1.62 (2.15%)

LPNT

LifePoint

$56.20

0.4 (0.72%)

THC

Tenet

$13.59

0.68 (5.27%)

UHS

Universal Health

$108.44

2.84 (2.69%)

HOG

Harley-Davidson

$47.51

0.94 (2.02%)

IONS

Ionis Pharmaceuticals

$63.85

2.7 (4.42%)

FCX

Freeport McMoRan

$14.93

-0.34 (-2.23%)

IPXL

Impax

$19.30

-0.65 (-3.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 18

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 27

    Oct

  • 31

    Oct

  • 02

    Nov

  • 02

    Nov

  • 06

    Nov

  • 08

    Nov

  • 09

    Nov

IBM

IBM

$146.41

-0.39 (-0.27%)

16:14
10/17/17
10/17
16:14
10/17/17
16:14
Hot Stocks
IBM reports Q3 Cognitive solutions revenue $4.4B, up 3% ex-currency »

Reports Q3 Global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 15

    Nov

16:14
10/17/17
10/17
16:14
10/17/17
16:14
General news
Treasury International Capital Foreign Demand for Long-Term U.S. Securities data reported »

August Treasury…

LLESY

Lendlease Group

$14.60

0.026 (0.18%)

16:14
10/17/17
10/17
16:14
10/17/17
16:14
Downgrade
Lendlease Group rating change  »

Lendlease Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$146.40

-0.4 (-0.27%)

16:13
10/17/17
10/17
16:13
10/17/17
16:13
Earnings
IBM backs FY17 adjusted EPS view of at least $13.80, consensus $13.75 »

Operating diluted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 15

    Nov

IBM

IBM

$146.43

-0.37 (-0.25%)

16:13
10/17/17
10/17
16:13
10/17/17
16:13
Hot Stocks
IBM reports Q3 cloud revenues up 20% to $4.1B »

Third-quarter cloud…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 15

    Nov

IBM

IBM

$146.45

-0.35 (-0.24%)

16:12
10/17/17
10/17
16:12
10/17/17
16:12
Earnings
IBM reports Q3 adjusted EPS $3.30, consensus $3.28 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 15

    Nov

COTY

Coty

$16.01

-0.82 (-4.87%)

16:12
10/17/17
10/17
16:12
10/17/17
16:12
Initiation
Coty initiated  »

Coty initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTRS

Northern Trust

$91.10

-0.82 (-0.89%)

16:11
10/17/17
10/17
16:11
10/17/17
16:11
Hot Stocks
Northern Trust CEO Frederick Waddell to step down »

Northern Trust announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

LRCX

Lam Research

$194.55

2.19 (1.14%)

16:10
10/17/17
10/17
16:10
10/17/17
16:10
Earnings
Lam Research sees Q2 EPS $3.65, +/- 12c, consensus $3.33 »

Sees Q2 revenue $2.55B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

CREE

Cree

$29.34

0.06 (0.20%)

16:10
10/17/17
10/17
16:10
10/17/17
16:10
Earnings
Cree sees Q2 adjusted EPS (1c)-4c, consensus 7c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

PTX

Pernix Therapeutics

$2.76

-0.05 (-1.78%)

16:10
10/17/17
10/17
16:10
10/17/17
16:10
Hot Stocks
Pernix Therapeutics CFO Graham Miao to resign at the end of the year »

Pernix Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUSA

Houston American Energy

$0.43

-0.0128 (-2.88%)

16:09
10/17/17
10/17
16:09
10/17/17
16:09
Syndicate
Breaking Syndicate news story on Houston American Energy »

Houston American Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCSS

Select Comfort

$30.38

-0.17 (-0.56%)

16:09
10/17/17
10/17
16:09
10/17/17
16:09
Technical Analysis
Technical View: Select Comfort drops after earnings miss »

In the extended session…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

MOBL

MobileIron

$3.80

-0.1 (-2.56%)

16:09
10/17/17
10/17
16:09
10/17/17
16:09
Earnings
MobileIron sees Q3 revenue $42M-$43M, consensus $45.22M »

Sees Q3: Gross billings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCSG

Healthcare Services

$54.37

-0.08 (-0.15%)

16:08
10/17/17
10/17
16:08
10/17/17
16:08
Hot Stocks
Healthcare Services increases dividend to 19c per share »

Healthcare Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

MOBL

MobileIron

$3.80

-0.1 (-2.56%)

16:08
10/17/17
10/17
16:08
10/17/17
16:08
Hot Stocks
MobileIron CEO Barry Mainz to leave, Simon Biddiscombe to succeed »

MobileIron announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHEF

Chefs' Warehouse

$20.75

0.2 (0.97%)

16:07
10/17/17
10/17
16:07
10/17/17
16:07
Hot Stocks
Chefs' Warehouse announces resignation of CFO John Austin »

The Chefs' Warehouse…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCSS

Select Comfort

$30.38

-0.17 (-0.56%)

16:07
10/17/17
10/17
16:07
10/17/17
16:07
Earnings
Select Comfort narrows FY17 EPS view to $1.30-$1.45 from $1.25-$1.50 »

Consensus $1.39. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

LRCX

Lam Research

$194.32

1.95 (1.01%)

16:07
10/17/17
10/17
16:07
10/17/17
16:07
Earnings
Lam Research reports Q1 EPS $3.46, consensus $3.28 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

SCSS

Select Comfort

$30.38

-0.17 (-0.56%)

16:06
10/17/17
10/17
16:06
10/17/17
16:06
Hot Stocks
Select Comfort increases share repurchase authorization to $500M »

Select Comfort announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.